Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongwei Du

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
Meta Gene|June 23, 2016
ERBB3-rs2292239 as primary type 1 diabetes association locus among non-HLA genes in ChineseChengjun Sun, Haiyan Wei, Xiuli Chen, et al.
Journal for Immunotherapy of Cancer|January 14, 2022
Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumorsJiemiao Hu, Qing Yang, Wendong Zhang, et al.
Frontiers in Endocrinology|August 29, 2022
The pharmacokinetic and pharmacodynamic properties and short-term outcome of a novel once-weekly PEGylated recombinant human growth hormone for children with growth hormone deficiencyYan Liang, Cai Zhang, Haiyan Wei, et al.
Nature Biotechnology|February 5, 2020
Interleukin-23 engineering improves CAR T cell function in solid tumorsXingcong Ma, Peishun Shou, Christof Smith, et al.
International Immunopharmacology|April 28, 2025
Dual cytokine-engineered macrophages rejuvenate the tumor microenvironment and enhance anti-PD-1 therapy in renal cell carcinomaXin Liu, Ranran Jiang, Yujun Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 29, 2022
STING Suppresses Mitochondrial VDAC2 to Govern RCC Growth Independent of Innate ImmunityZhichuan Zhu, Xin Zhou, Hongwei Du, et al.
National Science Review|March 10, 2022
Scattered seeding of CAR T cells in solid tumors augments anticancer efficacyHongjun Li, Zejun Wang, Edikan A Ogunnaike, et al.
International Journal of Cancer|September 4, 2019
In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumabSara Caratelli, Roberto Arriga, Tommaso Sconocchia, et al.
Pediatric Diabetes|November 6, 2025
HLA-C<i>⁣</i> <sup><i>∗</i></sup> 0304 Associates With Beneficial Gut Microbiota and Later Onset of Type 1 Diabetes in Pediatric CohortsZhenran Xu, Xiaojing Li, Xiaoxiao Yuan, et al.
Clinical Endocrinology|November 8, 2024
A Phase 2 Study of PEGylated Recombinant Human Growth Hormone for 52 Weeks in Short Children Born Small for Gestational Age in ChinaXiaoping Luo, Ling Hou, Yan Zhong, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Meta Gene|June 23, 2016
ERBB3-rs2292239 as primary type 1 diabetes association locus among non-HLA genes in ChineseChengjun Sun, Haiyan Wei, Xiuli Chen, et al.
Journal for Immunotherapy of Cancer|January 14, 2022
Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumorsJiemiao Hu, Qing Yang, Wendong Zhang, et al.
Frontiers in Endocrinology|August 29, 2022
The pharmacokinetic and pharmacodynamic properties and short-term outcome of a novel once-weekly PEGylated recombinant human growth hormone for children with growth hormone deficiencyYan Liang, Cai Zhang, Haiyan Wei, et al.
Nature Biotechnology|February 5, 2020
Interleukin-23 engineering improves CAR T cell function in solid tumorsXingcong Ma, Peishun Shou, Christof Smith, et al.
International Immunopharmacology|April 28, 2025
Dual cytokine-engineered macrophages rejuvenate the tumor microenvironment and enhance anti-PD-1 therapy in renal cell carcinomaXin Liu, Ranran Jiang, Yujun Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 29, 2022
STING Suppresses Mitochondrial VDAC2 to Govern RCC Growth Independent of Innate ImmunityZhichuan Zhu, Xin Zhou, Hongwei Du, et al.
National Science Review|March 10, 2022
Scattered seeding of CAR T cells in solid tumors augments anticancer efficacyHongjun Li, Zejun Wang, Edikan A Ogunnaike, et al.
International Journal of Cancer|September 4, 2019
In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumabSara Caratelli, Roberto Arriga, Tommaso Sconocchia, et al.
Pediatric Diabetes|November 6, 2025
HLA-C<i>⁣</i> <sup><i>∗</i></sup> 0304 Associates With Beneficial Gut Microbiota and Later Onset of Type 1 Diabetes in Pediatric CohortsZhenran Xu, Xiaojing Li, Xiaoxiao Yuan, et al.
Clinical Endocrinology|November 8, 2024
A Phase 2 Study of PEGylated Recombinant Human Growth Hormone for 52 Weeks in Short Children Born Small for Gestational Age in ChinaXiaoping Luo, Ling Hou, Yan Zhong, et al.
Pageof 15